SCHEMBL178535

SCHEMBL178535

CCOc1cccc(C2=NOC3(CCC4(CC3)OCCO4)C2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
RAB9A P51151 2/20 0.40
HTT P42858 2/20 0.40
NPC1 O15118 1/20 0.40
BRD4 O60885 1/20 0.39
BRD2 P25440 1/20 0.39
CREBBP Q92793 1/20 0.39
SSTR5 P35346 2/20 0.39
KDM4E B2RXH2 5/20 0.38
MAPT P10636 3/20 0.38
GAA P10253 1/20 0.38
THRB P10828 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NOTUM Q6P988 1/20 0.37
S1PR1 P21453 2/20 0.37
TP53 P04637 3/20 0.36
HSD17B10 Q99714 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL178518 0.87 ALDH1A1 (0.51) ALDH1A1RAB9AHTTNPC1KDM4E
SCHEMBL178532 0.82 CHRNB4 (0.37) ALDH1A1RAB9AHTTNPC1SSTR5
SCHEMBL10227364 0.78 KIF11 (0.38) ALDH1A1RAB9AHTTNPC1KDM4E
SCHEMBL178519 0.78 CHRNB4 (0.37) ALDH1A1RAB9AHTTNPC1KDM4E
SCHEMBL178521 0.76 CLK4 (0.38) NOTUMCHRNB4CHRNA3
SCHEMBL178562 0.75 NOTUM (0.36) RAB9AHTTNPC1BRD4NOTUM
SCHEMBL12904308 0.74 MIF (0.43) ALDH1A1RAB9AHTTNPC1KDM4E
SCHEMBL2208887 0.72 CHRNB4 (0.45) ALDH1A1RAB9AHTTNPC1KDM4E
SCHEMBL2208848 0.68 ALDH1A1 (0.48) ALDH1A1RAB9AHTTNPC1KDM4E
SCHEMBL917142 0.68 PDE4A (0.39) ALDH1A1KDM4ETP53HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120059015-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS AS MGLU5 ANTAGONISTS RECORDATI IRELAND LTD. (IT) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059015-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS AS MGLU5 ANTAGONISTS GRM5, GPR65, GRIK5 ALDH1A1 1514/4885RAB9A 909/4885HTT 1186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.